Landscapes / Companies

CanSino Biologics Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
1 in Phase 3
Next date
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, Phase 1/2 trial completes
Drugs
8
in active trials · 21 in all
Trials
10 active
34 since 2021

Drugs8

DrugHow it worksPartnerStageNext dateDetails
—
Approved in China 24 Nov 2026soonPhase 1/2 trial completes
Batch 1 ofnot checked
—
Approved in China Feb 2029Phase 1 trial completes
—
Phase 3 —
—
Phase 1/2 24 Nov 2026soonPhase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1 Feb 2029Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About

No active trial
13 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow CanSino Biologics Inc.

Following is part of Solo: you see every change to CanSino Biologics Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in